ArticleScientific reports2025
Health related quality of life and its influencing factors in Chinese patients with ocular tumors.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundOcular tumors are a class of important ophthalmologic diseases that threaten patient visual acuity and health-related quality of life (HRQoL). However, little is known about the factors affecting HRQoL among individuals with ocular tumors in mainland China.
methodsConvenience sampling was employed to select 144 patients with ocular tumors being treated in a grade A tertiary hospital in Shanghai from August 2022 to May 2023 as study participants. A self-made general data questionnaire, the Medical Coping Modes Questionnaire (MCMQ), Fear of Progression Questionnaire Short Form (FoP-Q-SF), and Euro-Qol-5 Dimensions (EQ-5D-3 L) were used to conduct a cross-sectional survey. Multiple linear regression was performed to analyze the factors affecting QoL.
resultsThe mean EQ-5D-3 L visual analog score was 81.60 ± 17.66 and the most common problems reported by patients with ocular tumors were pain, discomfort, anxiety, and depression. The total MCMQ score was 39.88 ± 7.04, and the total FoP-Q-SF score was 25.24 ± 9.27. The health effects index was negatively correlated with avoidance (r = - 0.226, p < 0.05) and resignation dimensions (r = - 0.460, p < 0.05) and negatively correlated with total FoP-Q-SF score (r = - 0.491, p < 0.001). Multiple linear regression analysis showed that having a resignation coping style, high FOP, low visual acuity in the non-dominant eye, and diagnosis of malignant tumor is significantly associated with low HRQoL ( p < 0.05).
conclusionsThe HRQoL of patients with ocular tumors tends to be low. HRQoL in these patients is associated with increased MCMQ resignation domain score, FoP-Q-SF physical health domain score, definitive diagnosis of malignancy, and decreases in non-dominant eye visual acuity. We recommend that clinical staff focus on improving non-dominant eye visual acuity in patients with ocular tumors and improve their disease coping styles to decrease FOP, thereby increasing their QoL.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.